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L IVER TRANSPLANTATION has be-
come an accepted form of treatment for 
a variety of end-stage liver diseases. In addi-
tion to improved surgical techniques, impor-
[ant advances in the immunosuppressive 
treatment of hepatic allograft recipients have 
been made through the introduction of cyclo-
sporine (Cs) and, more recently, the addition 
of a T cell-specific murine monoclonal anti-
body (MoAb) OKT3 to treat acute rejection 
episodesY In spite of these achievements, 
allograft rejection remains a major problem in 
liver transplantation.3.4 
T lymphocytes playa major role in cell-
mediated allograft rejection. During the 
course of alloactivation, T cells are primed 
against donor antigens. Alloactivated T cells 
then express Interleukin-2 (IL-2) receptors on 
their cell surface, and IL-2 is required for 
their further propagation. Based on this 
rationale, IL-2 has been used to propagate 
alloactivated T cells in vitro from liver al1o-
graft biopsies. Earlier studies have demon-
strated the feasibility of these methodologies 
using IL-2 as a sole source of growth require-
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ment. Further analysis revealed proliferative 
as well as cytotoxic responses of these cultured 
cell lines to donor HLA antigens present on 
donor splenocytes. 5 We report results of our 
extended swdy which now includes 36 biop-
sies from 31 iiver transplant recipients. 
MATERIALS AND METHODS 
All liver transplant recipients received Cs and steroids 
as immunosuppressive drugs. Samples of hepatic allo-
grafts were obtained from percutaneous liver biopsies. 
intraoperative liver biopsies. or removed allografts. Indi· 
cations for sampling were derangements in liver function 
tests and bile composition. At times of allograft hepatec-
tomies, more extensive tissue samples were obtained, as 
were lymph node samples from the hilar region of the 
removed allograft." All samples were taken in a sterile 
manner for propagation of infiltrating cells and histologic 
evaluation. Liver biopsies were divided into smaller seg-
ments and cultured in microculture wells with 100 ILL of 
IL-2 and 100 ILL of tissue culture medium. The cultures 
were observed daily on an inverted-stage microscope and 
supplemented with IL-2 at 2- to 3-day intervals. After-2 
weeks, sufficient cells (0.5 to 1.0 x 106) were obtained for 
further studies. Cell surface phenotypic analysis of biop-
sy-grown T cells was achieved using a modification of the 
avidin-biotin-immunoperoxidase technique. Immuno-
staining was also done on lymphocyte suspensions 
extracted from rejected liver allografts. Primed lympho-
cyte testing (PL T) and cell· mediated lympholysis (CML) 
assays were performed. In blocking studies. different 
anti-class I and anti·class II MoAb were tested for their 
inhibitory effect on the PL T response of cultured biopsy T 
cells using previously described methods.s 
RESULTS 
Patient Profile 
Thirty-one liver allograft recipients pro-
vided 36 transplant biopsies at various time 
intervals after transplantation, ranging from 3 
days to 330 days. Samples were taken on 27 
occasions from first allografts and on nine 
occasions from second allografts. The popula-
tion of liver allograft recipients consisted of 
patients with end-stage liver failure due to a 
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variety of causes as well as patients with 
inborn errors of metabolism and hepatic 
malignancy. 
Phenotype Analysis 
Biopsy-grown lymphocytes were usually 
analyzed for cell surface phenotype markers 
after 2 to 4 weeks in culture. Analysis of five 
culture lines revealed a predominance of 
CD3-positive T lymphocytes, many of which 
also expressed DR antigens as an indication of 
activation. A mixture of CD4 and CD8 posi-
tive cells was found in most cultures, with a 
trend toward CD4 predominance. Two cell 
preparations extracted by mechanical disrup-
tion from rejected liver allografts showed phe-
notype profiles similar to those of biopsy-
grown cells. 
Allospecificity Determined in Secondary 
Proliferation Assays 
All tested cell lines exhibited low back-
ground thymidine incorporation, but a high 
proliferative response to IL-2, suggesting the 
presence of activated T cells. For 21 biopsy 
cultures, we had available cryopreserved sple-
nocytes from the original transplant donor. 
The majority of these biopsy-derived T cell 
culture lines showed a high proliferative 
response to original donor antigens present on 
splenocytes and informative panel cells of 
known HLA types. Table I shows representa-
tive examples of IL-2-induced and donor cell-
induced proliferation of cultured biopsy cells. 
Their specificity was determined against a 
panel of unrelated cells selected to share HLA 
antigens with the original transplant donor. In 
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most cases, the PL T specificity of biopsy-
grown cells corresponded to one or more class 
I and/or class II HLA antigens of the donor. 
Patient M.R. (Fig lA) was HLA-typed as 
A2,-;B35,-;DR4,7, and the corresponding 
donor was A25,32; BI8,60;DR2,4. Lympho-
cytes grown from a biopsy 17 days posttrans-
plant appeared to be specific against DR2 and 
DR4 antigens of the donor. Despite the fact 
that both recipient and donor carried the DR4 
antigen, the DR4 specificity can be explained 
by the complexity of the DR4 antigen. Patient 
c.L. (Fig IB) typed as Al,-;B8,62;DR2,3. 
The allograft from the first donor 
CA2,3l ;B38,41 ;DR5,6) was rejected after 18 
days. The second transplant came from a 
donor who typed as A2,3;BI4,44;DR4,7. 
Lymphocytes grown from a biopsy 6 days 
after retransplantation showed a high PLT 
response related to DR4 and DR7 antigens 
shared by the second donor. No significant 
proliferation was detected using spleen lym-
phocytes from the first donor as stimulators. 
Patient L. W. (A2,-;B3 5,51 ;DR4,6) re-
ceived a second liver allograft from a donor 
typed A3,II;B7,40;DR2,5. This transplant 
was rejected 25 months later, and lympho-
cytes grown from a biopsy obtained from the 
removed allograft showed a high proliferative 
response to DR2 and DR5 antigens shared by 
the second donor (data not shown). There was 
also strong proliferation of lymphocytes from 
this biopsy toward splenic cells from the donor 
(A2,28;B44,70;DRI,11) of the third liver 
transplant. Histologic examination of biopsies 
from this third allograft showed on day 10 
acute and day 28 partially treated rejection. 
Table 1. Proliferative Responses and Allospecificities of Liver Biopsy-Grown Lymphocytes 
Liver 
B,opsy 
1 
2 
3 
4 
5 
Background 
585 ± 105 
1,272 '" 585 
692:- 127 
1,612", 490 
335 j; 38 
Proliferative Responses (cpm ± SD) 
Exogenous IL-2 
12,815±9 
4,152:-170 
49.797 j; 1.085 
35,691 '" 2.097 
6.936 ± 380 
Abbreviations: IL-2, Interleukin-2; PL T. primed lymphocyte testing. 
PLT 
Donor-Stimulated Alloreactivity 
4.344 :- 1.385 DR7.DR4 
44,802 ± 1.280 A 11, DR6 
32,337 ± 943 DR2. DR4 
5 1.620 ± 2,005 Undetermined 
9,397 ± 1.395 B53.B44 
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Fig 1. Primed lymphocyte testing (PL T) specificities 
of T lymphocytes grown from liver allograft biopsies. 
Tritiated thymidine uptake was determined in 3-day 
proliferation assays. HLA antigens of the panel cells are 
listed: those shared with the donor are underlined. A: 
Results from lymphocytes obtained from a biopsy of a 
removed allograft 17 days posttransplant from patient 
M.R. Background proliferation in 10% AB serum was 
692 ± 127. B: PL T results from Iymphocytes,obtained 
from a biopsy 6 days after retransplantation from 
patient C.L. Splenocytes from both the second trans-
plant donor and the first donor were used as stimula-
tors. Background proliferation in 10% AB serum was 
928 ± 245. 
Finally, this graft· had to be removed with 
additional signs of ischemic injury. 
Serial Biopsies 
Serial liver biopsies were obtained from 
four liver allograft recipients. One patient had 
allograft biopsies on day 9 and day 13 after 
transplant. PLT specificity of cells grown 
from the early biopsy corresponded to class I 
antigens, whereas cells from the later biopsy 
appeared to be specific for class I and class II 
antigens. Two T cell lines grown from biopsies 
of two consecutive allografts from a second 
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patient both showed class II antigen specific-
ity. Another patient received two consecutive 
allografts. T cells from the biopsy of the first 
allograft appeared to be specific for donor 
class I antigens, whereas T cells from two 
subsequent biopsies of the second allograft 
both showed PL T specificity against a mix-
ture of class [ and class II antigens. In one 
patient, an OKT) MoAb treatment was 
started 4 days after transplantation of the 
hepatic allograft. T cell lines from day 3 
posttransplant and day 17 (14 days from start 
of OKT) treatment) both showed class [ PL T 
reactivity, with a possible weak class II effect 
for the later one. The class I reactivity was 
confirmed by MoAb inhibition studies with 
41.5% and 57.7% inhibition of class I activity, 
respectively. After 2 weeks of OKT3 adminis-
tration, the treatment was not yet successful 
and was subsequently extended for another 7 
days. The patient then responded well to the 
therapy. 
DISCUSSION 
These studies further extend our previous 
observations that alloactivated T cells can be 
readily propagated from liver transplant biop-
sies.5•7•8 They demonstrated that it is possible 
to culture these cells in IL-2 without the 
requirement of any type of exogenous feeder 
cells, which means that the current methodol-
ogy minimizes the risk of de novo activation of 
cultured intragraft T lymphocytes. The IL-2 
responsiveness and HLA-specific PL T reac-
tivity demonstrate the presence of donor-
specific alloactivated T cells in lymphocyte 
cultures grown from the liver transplant biop-
sies. 
Phenotypic analysis revealed that both 
CD4- and CD8-positive lymphocytes can be 
propagated from liver allograft biopsies. 
There did not appear to be a consistent pattern 
of either CD4 or CD8 in association to class I 
or class II allospecificities. A trend toward 
predominance of CD4-bearing lymphocytes 
was noted. On two occasions, we were able to 
compare phenotypic analysis of biopsy-grown 
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lymphocytes with in situ lymphocytes ob-
tained from allograft tissues at times of allo-
graft removal. Both showed similar patterns 
of CD4 and CD8 cell surface markers. 
Both class I and class II antigens on donor 
lymphoid cells can serve as recognition anti-
gens in proliferation and cytotoxicity assays 
for biopsy-derived T cells. Panel cell analysis 
indica tes that the PL T response to donor 
alloantigens may often be restricted to a few 
HLA antigens. We have preliminary evidence 
for a time-related pattern showing that during 
the early posttransplant period generally more 
class I-specific T cells can be grown from the 
allograft. Later, the biopsy cultures tend to 
contain mixtures of class I-and class II-
specific cells or, often, predominantly class 
II-specific cells. When serial biopsies from 
allograft recipients were obtained, a shift 
from a class I PLT activity pattern to a 
mixture of class I and class II specificities was 
often observed. This is in accordance with 
findings in the heart allograft in which a 
sequential infiltration pattern has been 
described.8 Exceptions may occur, however, 
whereby early biopsies generate only class 
II-specific T cells. 
Ongoing studies on limiting dilution analy-
sis of biopsy-derived T cell cultures have dem-
onstrated clones specific for donor antigens in 
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concordance to specificities of bulk culture 
lines as defined in PL T assays with panel cells. 
A small number of clones exhibit no PL T 
response toward donor lymphoid cells al-
though they proliferate well in the presence of 
IL-2. It is not known whether these lympho-
cytes have been sensitized to other non-HLA 
antigens (eg, vascular endothelial antigens) or 
whether they have different functions. 
We have previously shown that the PL T 
response of cultured-biopsy lymphocytes can 
be inhibited by various defined anti-HLA 
MoAbs.s This further confirms the class 1- or 
class II -associated specificity patterns found 
in secondary proliferation assays using panel 
cells. Several biopsy-derived lymphocytes 
have also shown cytolytic activity against 
donor targets. Using PHA-transformed T 
Iymphoblasts (class I targets) and Epstein-
Barr virus (EBV)-transformed B lymphoblas-
toid cell lines (class I and class II targets), we 
were able to demonstrate that cytolytic activ-
ity of certain biopsy-grown cells was specific 
for class I antigens whereas others recognized 
class II antigens or both.5,9 
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